We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $20.45 · 11 analysts
Stored first · Google News · Yahoo Finance (English)
Healthcare Realty Trust (NYSE:HR) Reaches New 1-Year High - Here's What Happened - MarketBeat
Healthcare Realty Trust (NYSE:HR) Reaches New 1-Year High - Here's What Happened MarketBeat
Healthcare Realty Trust stock hits 52-week high at 20.9 USD - Investing.com Nigeria
Healthcare Realty Trust stock hits 52-week high at 20.9 USD Investing.com Nigeria
Healthcare Realty Trust Is Maintained at Neutral by JP Morgan - Moomoo
Healthcare Realty Trust Is Maintained at Neutral by JP Morgan Moomoo
Healthcare Realty Trust (NYSE:HR) Price Target Raised to $21.00 - MarketBeat
Healthcare Realty Trust (NYSE:HR) Price Target Raised to $21.00 MarketBeat
UBS Adjusts Price Target on Healthcare Realty Trust to $21 From $20, Maintains Neutral Rating
Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | — | — | — | $278.81M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.13 | — | — | $6.39M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-1.49 | — | — | $13.53M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-1.22 | — | — | $8.51M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 15. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 05. 13. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 05. 09. | Scotiabank | — | Maintain | Sector Outperform → Sector Outperform | — | Scotiabank: Sector Outperform |
| 2026. 05. 08. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 05. 04. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 04. 21. | UBS | — | Initiate coverage | — → Neutral | — | UBS: Neutral |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.